Following last week’s near 4% decline, Medibank Private Ltd (ASX: MPL) shares have climbed steadily today to be trading 4 cents or 1.7% higher at $2.35 per share, compared to a 0.3% rise from the benchmark S&P/ASX 200 Index (Index: ^AXJO) (ASX: XJO).
Source: Google Finance
Indeed, there has been much debate regarding what the Medibank stock is really worth. While many investors – myself included – were of the belief it was expensive at its $2.00 initial public offer price, others have suggested it will climb as high as $2.62. One analyst from Bank of America Merrill Lynch even has a $3.00 price target for the stock.
While both of those targets are achievable, the insurer would need to show it has made significant progress in reducing costs and improving margins when it delivers its half-year and full-year results in February and August, respectively.
Until it can do so, Medibank Private remains an expensive investment prospect, and one that investors should avoid until such time that the company can justify its current price tag.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest.
- Coronavirus (COVID-19): 6 charts every Australian needs to see – April 6, 2020 1:46pm
- Innovation through crisis – April 2, 2020 11:48am
- Coronavirus (Covid-19): Why Is Italy’s Fatality Rate So Bad? – March 26, 2020 3:39pm